E-LIB Suche - Ergebnisse für: Casal, G. Alonso

1

99P Molecular correlates and treatment outcomes of patients..:

Pretelli, G. ; Laimito, K.I. Rojas ; Casal, G. Alonso...
ESMO Open. 9 (2024) - p. 102325 , 2024

Link: https://doi.org/10.1016/..

2

29O Clinical characterization of long-term survivors in pha..:

Mirallas, O. ; Rossi, A. ; Fernández, E.M....
ESMO Open. 9 (2024) - p. 102357 , 2024

Link: https://doi.org/10.1016/..

3

93P Evolving landscape of targeted therapies (TT) in early ..:

Rossi, A. ; Braña, I. ; Villar, M. Vieito...
ESMO Open. 9 (2024) - p. 102319 , 2024

Link: https://doi.org/10.1016/..

4

77P Impact of germline HLA genotypes on clinical outcomes i..:

Vieito Villar, M. ; Rojas Laimito, K.I. ; López, D....
ESMO Open. 8 (2023) 1 - p. 100935 , 2023

Link: https://doi.org/10.1016/..

5

51P Toxicity profile in early clinical trials with fibrobla..:

Rojas Laimito, K.I. ; Vieito Villar, M. ; Fullana Grimalt, B....
ESMO Open. 8 (2023) 1 - p. 100909 , 2023

Link: https://doi.org/10.1016/..

6

118O Definitive results for NSCLC and bladder cancer cohort..:

Melero, I. ; De Miguel, M.J. ; Casal, G. Alonso...
Immuno-Oncology and Technology. 20 (2023) - p. 100590 , 2023

Link: https://doi.org/10.1016/..

7

Tevatron Combination of Single-Top-Quark Cross Sections and..:

Aaltonen, Timo Antero ; Abazov, Victor Mukhamedovich ; Amerio, Silvia...
info:eu-repo/semantics/altIdentifier/pmid/pmid:26550718. , 2015

Link: https://bib-pubdb1.desy...

8

A phase II trial of erlotinib as maintenance treatment afte..:

Casal Rubio, J. ; Fírvida-Pérez, J. L. ; Lázaro-Quintela, M....
Cancer Chemotherapy and Pharmacology. 73 (2013) 3 - p. 451-457 , 2013

Link: https://doi.org/10.1007/..

9

The stellar occultation by (319) Leona on 2023 September 13..:

Ortiz, J L ; Kretlow, M ; Schnabel, C...
Monthly Notices of the Royal Astronomical Society: Letters. 528 (2023) 1 - p. L139-L145 , 2023

Link: https://doi.org/10.1093/..

10

An overview of the scientific contribution of Andrea Vittur..:

Fortunato, L. ; Alonso, C. E. ; Arias, J. M....
The European Physical Journal A. 56 (2020) 2 - p. , 2020

Link: https://doi.org/10.1140/..

11

9058 POSTER A Phase II Trial of Eriotinib as Maintenance Tr..:

Casal, J. ; Firvida, J.L. ; Lázaro, M....
European Journal of Cancer. 47 (2011) - p. S609 , 2011

Link: https://doi.org/10.1016/..

12

P-589 Gemcitabineldocetaxel (GD) vs gemcitabinelcisplatin (..:

Vázquez, S. ; Casal, J. ; Vázquez, F....
Lung Cancer. 49 (2005) - p. S273 , 2005

Link: https://doi.org/10.1016/..

13

Selpercatinib in Patients With RET Fusion–Positive Non–Smal..:

Drilon, Alexander ; Gautschi, Oliver ; Tomasini, Pascale...
Journal of Clinical Oncology;41(2). , 2023

Link: https://hdl.handle.net/1..

14

A phase II randomized trial of gemcitabine-docetaxel versus..:

As representatives of the Galician Group of Lung Cancer (GGCP in the Spanish acronym) ; Rubio, Joaquín Casal ; Vázquez, S....
Cancer Chemotherapy and Pharmacology. 64 (2009) 2 - p. 379-384 , 2009

Link: https://doi.org/10.1007/..

15

Contributors:

, In: Pediatric Critical Care,

Ackerman, Veda L. ; Adelson, P. David ; Agbeko, Rachel S.... - p. v-xxii , 2011

Link: https://doi.org/10.1016/..